← Back to Overview

How It Works

PEA is a fatty-acid amide the body makes naturally. It does not work like a classic H1 antihistamine such as fexofenadine. Instead, research suggests it can downmodulate mast-cell activity and other inflammatory signaling while also affecting pathways involved in nerve sensitization and pain.

Mast cells & histamine

May turn down mast-cell activation rather than block H1 receptors

PEA is not a classic antihistamine. Experimental research suggests it can downmodulate mast-cell activation and degranulation, which is the process mast cells use to release histamine and other mediators. In a randomized allergic-rhinitis trial, PEA supplementation was also associated with lower circulating histamine and several inflammatory markers.

Human allergy study →

Inflammatory signaling

PPAR-alpha is one of PEA’s best-described molecular targets

PEA can activate PPAR-alpha, a receptor that helps regulate the expression of inflammatory genes. This pathway can reduce signaling through inflammatory transcription factors such as NF-kB and may help explain why PEA is studied across inflammatory and pain conditions.

Mechanism review →

Nerve & pain signaling

PEA also affects neuroimmune pathways involved in sensitization

Research describes effects involving microglia, TRPV1, and endocannabinoid-related signaling. These pathways are relevant to nerve sensitization and help explain why much of PEA’s human evidence is in neuropathic and chronic pain rather than histamine alone.

Neuroinflammation review →

Why formulation matters

PEA is poorly water-soluble, so particle size and formulation can affect how well it disperses and is absorbed. Micronized and ultramicronized forms reduce particle size, which is one reason formulation matters when comparing PEA products.

Formulation & pharmacokinetics review →